HTS: Publications by John H. Greist, MD

Hoehn-Saric R, Ninan P, Black DW, Stahl S, Greist JH, Lydiard B, McElroy S, Zajecka J, Chapman D, Clary C, Harrison W: Multicenter Double-blind Comparison of Sertraline and Desipramine for Concurrent Obsessive-Compulsive Disorder and Major Depressive Disorders. Arch Gen Psychiatry 57(1):76-82, 2000.

Nakagawa A, Marks IM, P JM, Bachofen M, Baer L, Dottl SL and Greist JH: Self-Treatment of Obsessive-Compulsive Disorder Guided by Manual and Computer-Conducted Telephone Interview. Journal of Telemedicine and Telecare 6:22-26, 2000.

Kobak KA, Mundt JC, Greist JH, Katzelnick DJ and Jefferson JW: Computer Assessment of Depression: Automating the Hamilton Depression Rating Scale. Drug Information Journal 34(1):145-156, 2000. Abstract

Marks IM, O'Dwyer AM, Meehan O, Greist JH, Baer L and McGuire P: Subjective Imagery in Obsessive-Compulsive Disorder Before and After Exposure Therapy. British Journal of Psychiatry 176:387-391, 2000.

Greist JH, Osgood-Hynes DJ, Baer L and Marks IM: Technology-Based Advances in the Management of Depression. Focus on the COPE Program. Disease Management & Health Outcomes 7(4):193-200, 2000.

Mundt JC, Freed DM and Greist JH: Lay Person-Based Screening for Early Detection of Alzheimer's Disease: Development and Validation of an Instrument. Journal of Gerontology/Psychological Sciences 55B(3):P163-P170, 2000. Abstract

Greist JH and Hartley B: Research Digests. OCD Newsletter (Newsletter of the Obsessive Compulsive Foundation, New Haven, CT) 14(issues 1-6), 2000.

Katzelnick DJ and Greist JH: Social Anxiety Disorder: An Unrecognized Problem in Primary Care. Journal of Clinical Psychiatry 62(suppl 1):11-16, 2001. Abstract

Mundt JC, Kaplan DA and Greist JH: Meeting the Need for Public Education About Dementia. Alzheimer Disease and Associated Disorders 15(1):26-30, 2001.

Mundt JC, Clarke GN, Burroughs D, Brenneman DO and Greist JH: Effectiveness of Antidepressant Pharmacotherapy: The Impact of Medication Compliance and Patient Education. Depression and Anxiety 13:1-10, 2001.

Christensen DD and Greist JH: The Challenge of Obsessive-Compulsive Disorder Hoarding. Primary Psychiatry 8(2):79-86, 2001.

Fava M, Dunner DL, Greist JH, Preskorn SH, Trivedi MH, Zajecka J and Cohen M: Efficacy and Safety of Mirtazapine in Major Depressive Disorder Patients After SSRI Treatment Failure: An Open-Label Trial. Journal of Clinical Psychiatry 62(6):413-420, 2001.

Katzelnick DJ, Kobak KA, DeLeire T, Henk HJ, Greist JH, Davidson JRT, Schneier FR, Stein MB and Helstad CP: Impact of Generalized Social Anxiety Disorder in Managed Care. American Journal of Psychiatry 158(12):1999-2007, 2001. Abstract

Mundt JC, Ferber KL, Rizzo M and Greist JH: Computer-Automated Dementia Screening Using a Touch-Tone Telephone. Arch Intern Med 161(20):2481-2487, 2001. Abstract

Greist JH and Hartley B: Research Digests. OCD Newsletter (Newsletter of the Obsessive Compulsive Foundation, New Haven, CT) 15(issues 1-6), 2001.

Agel J, Rockwood T, Mundt JC, Greist JH and Swiontkowski M: Comparison of Interactive Voice Response and Written Self-Administered Patient Surveys for Clinical Research. Orthopedics 24(12):1155-1157, 2001.

Greist JH, Marks IM, Baer L, Kobak KA, Wenzel KW, Hirsch MJ, Mantle JM and Clary CM: Behavior Therapy for Obsessive-Compulsive Disorder Guided by a Computer or by a Clinician Compared With Relaxation as a Control. Journal of Clinical Psychiatry 63(2):138-145, 2002. Abstract

Greist JH, Mundt JC and Kobak KA: Factors Contributing to Failed Trials of New Agents: Can Technology Prevent Some Problems? Journal of Clinical Psychiatry (Supplement) 63(2):8- 13, 2002. Abstract

Mundt, J.C., Marks, I.M., Shear, M. K., & Greist, J. H. (2002). The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Brit. J. Psychiatry. 180:461-464. Abstract

Mataix-Cols D, Marks IM, Greist JH, Kobak KA and Baer L: Obsessive-Compulsive Symptom Dimensions as Predictors of Compliance With and Response to Behaviour Therapy: Results From a Controlled Trial. Psychotherapy and Psychosomatics 71:255-262, 2002.

Greist JH, Bandelow B, Hollander E, Marazziti D, Montgomery SA, Nutt DJ, Okasha A, Swinson RP and Zohar J: WCA Recommendations for the Long-Term Treatment of Obsessive-Compulsive Disorder in Adults. CNS Spectrums 8(8, Suppl 1):7-16, 2003.

Pollack MH, Allgulander C, Bandelow B, Cassano GB, Greist JH, Hollander E, Nutt DJ, Okasha A and Swinson RP: WCA Recommendations for the Long-Term Treatment of Panic Disorder. CNS Spectrums 8(8, Suppl 1):17-30, 2003.

Ameringen Mvan, Allgulander C, Bandelow B, Greist JH, Hollander E, Montgomery SA, Nutt DJ, Okasha A, Pollack MH, Stein DJ and Swinson RP: WCA Recommendations for the Long-Term Treatment of Social Phobia. CNS Spectrums 8(8, Suppl 1):40-52, 2003.

Hollander E, Koran LM, Goodman WK, Greist JH, Ninan PT, Yang H, Li D and Barbato LM: A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Controlled-Release Fluvoxamine in Patients With Obsessive-Compulsive Disorder. Journal of Clinical Psychiatry 64(6):640-647, 2003.

Greist J, McNamara RK, Mallinckrodt CH, Rayamajhi JN and Raskin J: Incidence and Duration of Antidepressant-Induced Nausea: Duloxetine Compared with Paroxetine and Fluoxetine. Clinical Therapeutics 26(9):1446-1455, 2004.

Nierenberg AA, Trivedi MH, Ritz L, Burroughs D, Greist J, Sackeim H, Kornstein S, Schwartz T, Stegman D, Fava M and Wisniewski SR: Suicide Risk Management for the Sequenced Treatment Alternatives to Relieve Depression Study: Applied NIMH Guidelines. Journal of Psychiatric Research 38:583-589, 2004.

Byrom B, Stein D and Greist JH: A Hotline to a Better Data. Good Clinical Practice Journal 12(2):1-4, 2005.

Kobak KA, Katzelnick DJ, Sands G, King M, Greist JH and Dominski M: Prevalence and Burden of Illness of Migraine in Managed Care Patients. Journal of Managed Care Pharmacy 11(2):1-13, 2005.

Kobak KA, Taylor LVH, Bystritsky A, Kohlenberg CJ, Greist JH, Tucker P, Warner G, Futterer R and Vapnik T: St. John’s Wort Versus Placebo in Obsessive-Compulsive Disorder: Results From a Double-Blind Study. International Clinical Psychopharmacology 20(6):299-304, 2005.

Jefferson JW and Greist JH: Lithium. In: BJ Sadock and VA Sadock (eds.), Comprehensive Textbook of Psychiatry/VIII, vol. 2, Lippincott Williams & Wilkins, Philadelphia, PA, 2005, pp 2839-2851.

Jefferson JW and Greist JH: Lithium. In: BJ Sadock and VA Sadock (eds.), Comprehensive Textbook of Psychiatry/VII, vol. 2, Lippincott Williams & Wilkins, Philadelphia, PA, 2000, pp 2377-2390.

Park LT, Jefferson JW and Greist JH: Obsessive-Compulsive Disorder. In: Palmer KJ (ed.), Pharmacotherapy of Anxiety Disorders, Adis International, Auckland, New Zealand, 2000, pp 43-59.

Greist JH and Jefferson JW: Anxiety Disorders. In: HH Goldman (ed), Review of General Psychiatry (5th Edition), McGraw-Hill, New York, 2000, pp 284-300.

Greist JH and Jefferson JW: Obsessive-Compulsive Disorder. In: Gabbard GO (ed.), Treatments of Psychiatric Disorders - Third Edition, Volume 2, American Psychiatric Press, Inc., Washington, D.C., 2001, pp 1515-1537.

Greist JH: Treating Depressed Patients With Cardiovascular Disease: Raising the Bar for Standards of Safety. In: Psychiatry Direct (Highlights of the 2000 U.S. Psychiatric & Mental Health Congress, San Diego, CA) Galen Press: Ghent, NY, 2001, pp 8-10.

Greist JH and Baer L: Psychotherapy for Obsessive-Compulsive Disorder. In: Stein DJ and Hollander E (eds.), Textbook of Anxiety Disorders, American Psychiatric Publishing, Inc., Washington, DC, 2002, pp 221-233.

Greist JH: Clinical Efficacy and Use in Psychiatric Disorders (Section V Gabapentin ). In: Levy RH, Mattson RH, Meldrum BS and Perucca E (eds.), Antiepileptic Drugs – Fifth Edition, Lippincott Williams & Wilkins, 2002, pp 349-353.

Byrom B and Greist JH: Novel Use of Interactive Voice Response Systems in the Measurement of Clinical Endpoint Data in CNS Studies. In: Hughes G (ed), European Pharmaceutical Contractor, Samedan Pharmaceuticals, London, Autumn 2002, pp. 92-97.

Greist JH and Jefferson JW: Anxiety Disorders. In: Beers MH, Fletcher AJ, Jones TV, Porter R, Berkwits M, Kaplan JL (eds.), The Merck Manual of Medical Information, Second Home Edition, Merck Research Laboratories, Whitehouse Station, NJ, 2003, pp 605-613.

Jefferson JW and Greist JH: Lithium in Psychiatric Therapy. In: G Adelman and BH Smith (eds), Elsevier = s Encyclopedia of Neuroscience, 3rd enlarged and revised edition (CD ROM), Elsevier Science, The Netherlands, 2004.

Jefferson JW and Greist JH: Lithium. In: BJ Sadock and VA Sadock (eds.), Comprehensive Textbook of Psychiatry/VIII, vol. 2, Lippincott Williams & Wilkins, Philadelphia, PA, 2005, pp 2839-2851.

Greist JH, Jefferson JW and Katzelnick DJ: Social Anxiety Disorder: A Guide. (Booklet) Information Centers, Madison, WI, 1997, 2000.

Jefferson JW, Greist JH and Katzelnick DJ: Oxcarbazepine and Bipolar Disorder: A Guide. (Booklet) Information Centers, Madison, WI, in press.

Greist JH: Effective Behavioural Therapy Constrained: Dissemination is the Issue. Commentary in Obsessive-Compulsive Disorder, Maj M, Sartorius N, Okasha A and Zohar J (eds.), WPA Series Evidence and Experience in Psychiatry, Vol. 4, Wiley & Sons, New York, 2000.

Jefferson JW, Endicott J, Greist JH and Katzelnick DJ: Premenstrual Dysphoric Disorder: A Guide. (Booklet) Information Centers, Madison, WI, 2003.

Greist JH, Jefferson JW, Doody RS and Katzelnick DJ: Alzheimer’s Disease: A Guide. (Booklet) Information Centers, Madison, WI, 2004.

Myrick H, Greist JH, Davidson J: Psychiatric Applications of Anticonvulsants - Substance Abuse and Anxiety Disorders. Supported by an educational grant from Parke-Davis, 2000.

Kobak KA, Kremer C, Greist JH, Jefferson JW and Burroughs D: Prospective Naturalistic Study of Weight Change Associated with Mirtazapine Treatment for Depression. Poster presentation, National Institute of Mental Health, New Clinical Drug Evaluation Unit (NCDEU), 40th Annual Meeting, Boca Raton, Florida, May/June, 2000.

Mundt JC, Ferber K and Greist JH: Development of a Short, Informant-Based Screening Instrument for Dementias. Poster presentation, National Institute of Mental Health, New Clinical Drug Evaluation Unit (NCDEU), 40th Annual Meeting, Boca Raton, Florida, May/June, 2000.

Katzelnick DJ, Sands G, Kobak KA, Dominski M, Greist JH, King M and Harrison W: Prevalence and Burden of Illness of Migraine in an HMO Population. Poster presentation, 42nd Annual Scientific Meeting of the American Headache Society, Montreal, Quebec, June 23-25,2000.

Greist JH: Effective Behavioural Therapy Constrained: Dissemination is the Issue. Commentaries. In: M Maj, N Sartorius, A Okasha and J Zohar (eds.), Obsessive-Compulsive Disorder, John Wiley & Sons, Chichester, NY, 4:116-119, 2000.

Jefferson JW, Greist JH: A Double-Blind Comparison of Citalopram and Paroxetine in the Treatment of Patients with Depression and Anxiety. Poster presentation, 39th Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico, December 10-14, 2000.

Jefferson JW, Greist JH: Depression and Older People: Recognizing Hidden Signs and Taking Steps Toward Recovery. An educational program sponsored by Pfizer, Inc. (booklet), 2001.

Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ and Mundt JC: New Technologies to Improve Clinical Trials. Guest Editorial, Journal of Clinical Psychopharmacology 21(3):255-256, 2001.

Katzelnick DJ, Mundt JC, Greist JH and Jefferson JW: Remote Assessment of Dementia Severity Using Interactive Voice Response. Poster presentation, 40th Annual Meeting of the American College of Neuropsychopharmacology, December 9-13, 2001.

Dunn J, Kobak KA, Arakawa R and Greist JH: Methods for Assessing the Onset of Sexual Dysfunction With Antidepressant Treatment. Poster presentation, 40th Annual Meeting of the American College of Neuropsychopharmacology, December 9-13, 2001.

Greist JH: Costs of Depression; Long-Term Treatment Strategies; and Physical Symptoms of Depression (with Dunner, DL). JCP CNS Capsules, 3(1):1-8, April, 2002.

Kobak KA and Greist JH: Development and Validation of a Short Form of the Hamilton Depression Scale. Poster presentation, 155 th Annual Meeting of the American Psychiatric Association, Philadelphia, PA, May, 2002.

Kobak KA, Greist JH, Jefferson JW and Katzelnick DJ: Validation of a Computer Administered Version of the Liebowitz Social Anxiety Scale Administered by Telephone via Interactive Voice Response (IVR). Poster presentation, National Institute of Mental Health, New Clinical Drug Evaluation (NCDEU) 42 nd Annual Meeting, Boca Raton, FL, June, 2002.

Rayamajhi J, Lu Y, DeBrota D, Greist JH and Demitrack M: A Comparison Between Interactive Voice Response System and Clinician Administration of the Hamilton Depression Rating Scale. Poster presentation, National Institute of Mental Health, New Clinical Drug Evaluation Unit (NCDEU) 42nd Annual Meeting, Boca Raton, FL, June, 2002.

Kobak K, Dunn J, Greist JH, Arakawa R and Wenzel K: Assessing the Onset of Sexual Dysfunction With Antidepressant Treatment Using Interactive Voice Response Technology. The International Journal of Neuropsychopharmacology (Supplement) 5(1):S143, 2002.

Mundt JC and Greist JH: Dementia Screening: Sensitivity, Specificity, and the Relationships Between Self-Identified Memory Difficulty and Measures of Cognitive Performance on Computer-Automated Tasks Using an Interactive Voice Response (IVR) Telephone System. Poster presentation, 1 st Annual Dementia Congress, Chicago, IL, September, 2002.

Feltner DE, Kavoussi R, Haber H, Kobak KA, Greist JH and Pande AC: Evaluation of an Interactive Voice-Response (IVR) Ham-A in a Generalized Anxiety Disorder (GAD) Relapse Prevention Trial. Poster presentation, 41 st Annual Meeting of the American College of Neuropsychopharmacology, December 8-12, 2002.

Katzelnick DJ, Blackwell B, Mundt JC and Greist JH: Can a Short Dementia Screener Help Discriminate Alzheimers Disease From Vascular Dementia? Poster presentation, 41 st Annual Meeting of the American College of Neuropsychopharmacology, December 8-12, 2002.

Kuca B, Kobak KA, Gaidjunas A, Akylbekova M, Casey DE and Greist JH: Interactive Voice Response (IVR) Diary Methods to Reduce Retrospective Recall Bias in Sleep Studies. Poster presentation, 41 st Annual Meeting of the American College of Neuropsychopharmacology, December 8-12, 2002.

Greist JH (program chair), Davidson JRT, Finley PR, Nelson JC and Lieberman JA: Depression and Anxiety in Primary Care. DAWN (Depression & Anxiety Wellness Network) – Self-Study Workbook 1 (pp 23) and Newsletter 1 (pp 1-11), produced by Innovative Medical Education, Paramus, NJ, April, 2003.

DeBrota DJ, Engelhardt N, Mundt JC, Greist JH and Verfaille SJ: Dailey Assessment of Depression Severity with an Interactive Voice Response System (IVRS). Poster presentation, National Institute of Mental Health, New Clinical Drug Evaluation Unit (NCDEU) 43 rd Annual Meeting, Boca Raton, Florida, May, 2003.

Nierenberg AA, Trivedi MH, Ritz L, Wisniewski S, Quitkin F, Stegman D, Burroughs D, Greist J, Fava Maurizio F and Rush AJ: Star*D Safety Monitoring: Lessons From a Large Hybrid Study of Depression. Poster presentation, National Institute of Mental Health, New Clinical Drug Evaluation Unit (NCDEU) 44 th Annual Meeting, Phoenix, AZ, June, 2004.

DeBrota DJ, Mundt JC, Rayamajhi J and Greist JH: Correlations and Factor Structures Within Data From Contemporaneous Interactive Voice Response System and Clinician Administrations of the Hamilton Depression Rating Scale. Poster presentation, National Institute of Mental Health, New Clinical Drug Evaluation Unit (NCDEU) 44 th Annual Meeting, Phoenix, AZ, June, 2004.

Mundt JC, Rahn K, DeBrota DJ and Greist JH: Assessing Depression: How Much Time and Effort Does it Take Via Interactive Voice Response (IVR)? Poster presentation, National Institute of Mental Health, New Clinical Drug Evaluation Unit (NCDEU) 44 th Annual Meeting, Phoenix, AZ, June, 2004.

Wohlreich MM, Wilson MG, Mallinckrodt CH, Greist JH, Delgado PL, Watkin JG and Fava M: Immediate Switching of Antidepressant Therapy: Results From a Clinical Trial of Duloxetine. The International Journal of Neuropsychopharmacology 7(1):S351-S352, 2004 (Abstract from the XXIV CINP Congress, Paris, June 20-24).

Burt VK, Detke M, Fava M, Greist JH, Nelson JC and Rosenbaum JF: Integrating Mind and Body: Treating the Whole Patient to Remission. CNS News 6(7):29-34, July, 2004.

Moore HK, Wohlreich MM, Wilson MG, Mundt JC, Fava M, Mallinckrodt, Arnold L and Greist JH: A Novel Approach to Measuring Onset of Efficacy of Duloxetine in Mood and Painful Symptoms of Depression. Poster presentation, 43 rd Annual meeting of the American College of Neuropsychopharmacology (ACNP), San Juan, Puerto Rico, December 14, 2004.

Wohlreich MD, Moore HK, Mundt JC, Mallinckrodt CH, Greist JH, Arnold LM and Fava M: Daily Measurements Elucidate Effects of Initial Dosing of Duloxetine. Paper presentation, 158th Annual Meeting of the American Psychiatric Association, Atlanta, GA, May, 2005.

Mundt JC, DeBrota DJ, Moore HK and Greist JH: Memory Enhanced Retrospective Evaluation of Treatment (MERET): Anchoring Patients’ Perceptions of Clinical Change in the Past. Poster presentation, National Institute of Mental Health, New Clinical Drug Evaluation Unit (NCDEU) 45th Annual Meeting, Boca Raton, FL, June, 2005.

Katzelnick, DJ, Mundt JC, Kennedy SH, Eisfeld BS, Bouffard BB and Greist JH: Development and Validation of an Interactive Voice Response (IVR) Version of the Montgomery-Asberg Depression Rating Scale (MADRS). Poster presentation, National Institute of Mental Health, New Clinical Drug Evaluation Unit (NCDEU) 45th Annual Meeting, Boca Raton, FL, June, 2005.